Drug intelligence / Profile preview

CARTISOME

Development stage
Preclinical
Lead developer
Exostemtech
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intraarticular
01

Overview

CARTISOME is an investigational exosome-based therapeutic candidate developed by Exostemtech for the treatment of osteoarthritis. It consists of exosomes derived from stem cells, specifically mesenchymal stem cells (MSCs), which are engineered or selected for their regenerative and anti-inflammatory properties. These exosomes function as intercellular communication vehicles, delivering a bioactive cargo of proteins, lipids, and microRNAs directly to the joint environment. The therapy aims to stimulate chondrocyte proliferation and extracellular matrix synthesis while simultaneously modulating the inflammatory milieu by suppressing pro-inflammatory cytokines. By addressing both tissue degradation and chronic inflammation, CARTISOME is designed as a disease-modifying osteoarthritis drug (DMOAD) that potentially offers superior outcomes compared to traditional palliative treatments. It is currently in the IND-enabling phase of development.

Other names
Exostemtech exosome therapy for Osteoarthritis

Beyond the preview

Go deeper on CARTISOME.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CARTISOME.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call